Consternation as Congress proposal for autonomous prescribing AI coincides with the haphazard cuts at the FDA
- PMID: 40102664
- PMCID: PMC11920405
- DOI: 10.1038/s41746-025-01540-2
Consternation as Congress proposal for autonomous prescribing AI coincides with the haphazard cuts at the FDA
Abstract
We live in interesting regulatory times. In January, a bill was introduced to the US Congress proposing that AI “can qualify as a practitioner eligible to prescribe drugs” if overseen by the States and FDA. This a bold and contentious move. Even proponents of AI’s swift integration into medicine must recognize the deep paradox: this proposal emerges even as the FDA’s world-leading infrastructure for AI oversight faces dismantling.
Conflict of interest statement
Competing interests: T.D. declares no competing financial interests and a nonfinancial interest as a member of multiple study teams using LumineticsCore from Digital Diagnostics and as co-lead of Johns Hopkins University’s Bloomberg Distinguished Professorship Cluster on Global Advances in Medical Artificial Intelligence. T.D. is an Editor for npj Digital Medicine. T.D. played no role in the internal review or decision to publish this News and Views article. R.M. declares no nonfinancial interests and no competing financial interests. S.G. declares a nonfinancial interest as an Advisory Group member of the EY-coordinated "Study on Regulatory Governance and Innovation in the field of Medical Devices" conducted on behalf of the DG SANTE of the European Commission. S.G. declares the following competing financial interests: he has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd., Flo Ltd, ICURA ApS, Rock Health Inc., Thymia Ltd., FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, DG SANTE, Prova Health Ltd, Haleon plc and Ada Health GmbH and holds share options in Ada Health GmbH. S.G. is a News and Views Editor for npj Digital Medicine. S.G. played no role in the internal review or decision to publish this News and Views article.
Figures

Similar articles
-
Lessons Learned About Autonomous AI: Finding a Safe, Efficacious, and Ethical Path Through the Development Process.Am J Ophthalmol. 2020 Jun;214:134-142. doi: 10.1016/j.ajo.2020.02.022. Epub 2020 Mar 12. Am J Ophthalmol. 2020. PMID: 32171769
-
Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes.Res Sq [Preprint]. 2024 Mar 13:rs.3.rs-3979992. doi: 10.21203/rs.3.rs-3979992/v1. Res Sq. 2024. Update in: NPJ Digit Med. 2024 Jul 22;7(1):196. doi: 10.1038/s41746-024-01197-3. PMID: 38559222 Free PMC article. Updated. Preprint.
-
Determinants for scalable adoption of autonomous AI in the detection of diabetic eye disease in diverse practice types: key best practices learned through collection of real-world data.Front Digit Health. 2023 May 18;5:1004130. doi: 10.3389/fdgth.2023.1004130. eCollection 2023. Front Digit Health. 2023. PMID: 37274764 Free PMC article. Review.
-
Autonomous AI systems in the face of liability, regulations and costs.NPJ Digit Med. 2023 Oct 6;6(1):185. doi: 10.1038/s41746-023-00929-1. NPJ Digit Med. 2023. PMID: 37803209 Free PMC article. Review.
-
Lessons on regulation and implementation from the first FDA-cleared autonomous AI - Interview with Chairman and Founder of Digital Diagnostics Michael Abramoff.Healthc (Amst). 2023 Jun;11(2):100692. doi: 10.1016/j.hjdsi.2023.100692. Epub 2023 May 16. Healthc (Amst). 2023. PMID: 37201476 No abstract available.
Cited by
-
Overcoming regulatory barriers to the implementation of AI agents in healthcare.Nat Med. 2025 Jul 18. doi: 10.1038/s41591-025-03841-1. Online ahead of print. Nat Med. 2025. PMID: 40681675 No abstract available.
References
-
- Rep. Schweikert, D. [R-A.-1. Text—H.R.238—119th Congress (2025-2026): Healthy Technology Act of 2025. https://www.congress.gov/bill/119th-congress/house-bill/238/text (2025).
-
- Proposed legislation paves the way for AI to prescribe drugs. MobiHealthNewshttps://www.mobihealthnews.com/news/proposed-legislation-paves-way-ai-pr... (2025).
-
- Commissioner, O. of the. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. FDAhttps://www.fda.gov/news-events/press-announcements/fda-permits-marketin... (2020).
-
- Salt, H. Europe Greenlights World’s First Autonomous AI for Skin Cancer Detection. FMAI Hubhttps://www.fmai-hub.com/europe-greenlights-worlds-first-autonomous-ai-f... (2025).
Grants and funding
LinkOut - more resources
Full Text Sources